Abstract
Objectives The automatic detection of acute ischemic stroke (AIS) and hemorrhagic infarction (HI) based on deep learning could avoid missed diagnosis. The fully supervised learning requires the amount of time and the expertise to manually outline lesions, which limits its applicability. The weakly supervised learning has the potential to reduce the labeling workload. The purpose of this study was to evaluate a weakly supervised method in detection of AIS and HI location using DWI.
Methods We proposed to adopt weakly supervised learning to spatially-locate AIS lesions by residual neural network (ResNet) and visual geometry group (VGG) network. On an AIS dataset, the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity and precision were calculated. Next, ResNet, which presented superior performance on the AIS dataset, was further applied to an HI dataset.
Results In the AIS dataset, the AUCs of ResNet and VGG on identifying image slices with AIS were 0.97 and 0.94, respectively. On spatially-locating the AIS lesions, ResNet provided higher sensitivity and a lower missed diagnosis rate than VGG, especially for pontine AIS lesions. In the HI dataset, the sensitivity of ResNet was 87.73% for AIS detection, and 86.20% for HI detection, respectively.
Conclusions Weakly supervised learning can effectively detect the location of AIS and HI lesions in DWI, which is of paramount importance in avoiding misdiagnosis in clinical scenario.
Key points The deep weakly supervised learning can reduce the labeling workload; ResNet can obtain more exact results, especially for pontine AIS lesions; Weakly supervised learning can effectively detect AIS and HI lesions in DWI
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study protocol was approved by the institutional review board of our center, which waived written informed consent due to the retrospective nature of the study.
Funding Statement
This work was supported in part by Natural Science Foundation of China (NSFC) (81771806, 81871342, 61871235) and in part by the Fundamental Research Funds for the Central Universities, Nankai University (63191106, 63185021).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Some or all data, models, or code generated or used during the study are available from the corresponding author by request.
Abbreviations and acronyms
- ResNet
- residual neural network
- VGG
- visual geometry group
- mFP-L
- mean number of false positive lesions
- mFN-L
- mean number of false negative lesions
- FD-S
- failed detected subjects
- LI
- lacunar infarction
- TI
- territorial infarction
